ARTICLE | Emerging Company Profile

Ribbon: high-throughput enzymatic assembly of long DNA molecules

Vienna-based Ribbon aims to reduce a bottleneck in the development of biologics

December 15, 2022 9:32 PM UTC

Ribbon Biolabs is automating the assembly of DNA sequences using an enzymatic approach that yields faster production of DNA molecules than standard chemical techniques and longer DNA sequences, of up to 20,000 base pairs, than other enzymatic approaches.

DNA synthesis has gotten faster and cheaper primarily through major players, such as Twist Bioscience Corp. (NASDAQ:TWST) and the Integrated DNA Technologies (IDT) unit of Danaher Corp., driving innovation through hardware improvements that miniaturize standard chemical synthesis methods...